News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Steinhart Richard I
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/16/2023 |
4
| Steinhart Richard I (CFO) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Exercised 521 restricted stock units
@ $0 |
|
| 05/16/2023 |
4
| Steinhart Richard I (CFO) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Sold 5,000 shares
@ $27.1727, valued at
$135.9k
Exercised 5,000 restricted stock units
@ $0 |
|
| 05/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/05/2023 |
4
| Steinhart Richard I (Director) has filed a Form 4 on ATOSSA THERAPEUTICS, INC.|
Txns:
| Granted 125,000 options to buy
@ $0.662, valued at
$82.8k
|
|
| 03/16/2023 |
4
| Steinhart Richard I (CFO) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Sold 2,084 shares
@ $19.5, valued at
$40.6k
Exercised 2,084 restricted stock units
@ $0
Granted 9,000 restricted stock units
@ $0
Granted 32,000 options to buy
@ $19.6, valued at
$627.2k
|
|
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/16/2022 |
4
| Steinhart Richard I (Director) has filed a Form 4 on ATOSSA THERAPEUTICS, INC.|
Txns:
| Granted 50,000 options to buy
@ $0.93, valued at
$46.5k
|
|
| 03/16/2022 |
4
| Steinhart Richard I (CFO) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Granted 8,337 restricted stock units
@ $0
Granted 33,350 options to buy
@ $15.31, valued at
$510.6k
|
|
| 09/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2021 |
4
| Steinhart Richard I (Director) has filed a Form 4 on ATOSSA THERAPEUTICS, INC.|
Txns:
| Granted 50,000 options to buy
@ $2.9, valued at
$145k
|
|
| 03/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/28/2020 |
4
| Steinhart Richard I (CFO) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Granted 55,000 options to buy
@ $45.99, valued at
$2.5M
|
|
| 05/19/2020 |
4
| Steinhart Richard I (Director) has filed a Form 4 on ATOSSA THERAPEUTICS, INC.|
Txns:
| Granted 45,000 options to buy
@ $1.7, valued at
$76.5k
|
|
| 07/16/2019 |
4
| Steinhart Richard I (Director) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Granted 250,000 options to buy
@ $0.232, valued at
$58k
|
|
| 05/21/2019 |
4
| Steinhart Richard I (Director) has filed a Form 4 on ATOSSA GENETICS INC|
Txns:
| Granted 45,000 options to buy
@ $2.52, valued at
$113.4k
|
|
| 12/04/2018 |
4
| Steinhart Richard I (CFO) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Bought 500 shares
@ $5.1999, valued at
$2.6k
|
|
| 11/30/2018 |
4
| Steinhart Richard I (CFO) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Bought 500 shares
@ $5, valued at
$2.5k
|
|
| 11/30/2018 |
4
| Steinhart Richard I (CFO) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Bought 500 shares
@ $5, valued at
$2.5k
|
|
| 07/17/2018 |
4
| Steinhart Richard I (Director) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Granted 75,000 options to buy
@ $0.7829, valued at
$58.7k
|
|
| 06/29/2018 |
4
| Steinhart Richard I (Director) has filed a Form 4 on ATOSSA GENETICS INC|
Txns:
| Granted 45,000 options to buy
@ $2.38, valued at
$107.1k
|
|
| 03/13/2018 |
4
| Steinhart Richard I (CFO) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Granted 32,232 options
@ $11, valued at
$354.6k
|
|
| 03/08/2018 |
4
| Steinhart Richard I (Director) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Acquired 7,000 shares
@ $0.5, valued at
$3.5k
Acquired 1,750 options to buy
@ $0.6, valued at
$1.1k
Acquired 5,250 options to buy
@ $0.7, valued at
$3.7k
|
|
| 03/07/2018 |
3
| Steinhart Richard I (CFO) has filed a Form 3 on BioXcel Therapeutics, Inc. |
| 05/26/2017 |
4
| Steinhart Richard I (Director) has filed a Form 4 on ATOSSA GENETICS INC|
Txns:
| Granted 49,531 options to buy
@ $0.47, valued at
$23.3k
|
|
| 03/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/19/2016 |
4
| Steinhart Richard I (Director) has filed a Form 4 on ATOSSA GENETICS INC|
Txns:
| Granted 71,484 options to buy
@ $0.263, valued at
$18.8k
|
|
| 04/18/2016 |
4
| Steinhart Richard I (Director) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Bought 2,500 shares
@ $2.01, valued at
$5k
Granted 75,000 options to buy
@ $1.99, valued at
$149.3k
|
|
| 05/14/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/16/2015 |
4
| Steinhart Richard I (Director) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Granted 25,000 options to buy
@ $3.58, valued at
$89.5k
|
|
| 05/08/2014 |
4
| Steinhart Richard I (Director) has filed a Form 4 on ATOSSA GENETICS INC|
Txns:
| Disposed/sold 22,728 shares
@ $0
Granted 15,000 options to buy
@ $1.22, valued at
$18.3k
|
|
| 03/04/2014 |
4
| Steinhart Richard I (Director) has filed a Form 4 on ATOSSA GENETICS INC|
Txns:
| Granted 22,728 shares
@ $0
Granted 16,484 options to buy
@ $2.2, valued at
$36.3k
|
|
|
|
|